J. Usakewicz

Phase II study of tallysomycin S10b in patients with advanced head and neck cancer

W. Hong, M. Rozencweig, I. Krakoff, 1990, Investigational New Drugs.

A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.

J. Buyniski, R. L. Cavanagh, J. Usakewicz, 1983, The Journal of pharmacology and experimental therapeutics.

Ifosfamide plus doxorubicin in metastatic adult sarcomas: a multi-institutional phase II trial.

J. Hainsworth, G. Sledge, P. Loehrer, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of chimeric (human-mouse) monoclonal antibody L6 in patients with non-small-cell lung, colon, and breast cancer

J. Murray, G. Goodman, I. Hellstrom, 1993, Cancer Immunology, Immunotherapy.

Phase II study of semisynthetic paclitaxel in metastatic breast cancer.

G. Hortobagyi, C. Hudis, L. Norton, 1997, European journal of cancer.

Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor.

L. Norton, H. Thaler, N. Onetto, 1995, Journal of the National Cancer Institute.